Recombinant bacille Calmette–Guérin (BCG) expressing human interferon-alpha 2B demonstrates enhanced immunogenicity

Overview of attention for article published in Clinical & Experimental Immunology, December 2001

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (81st percentile)
Good Attention Score compared to outputs of the same age and source (71st percentile)

Mentioned by

patent: 8 patents

Readers on

mendeley: 18 Mendeley

So far, Altmetric has seen 8 patents that reference this research output.

Methods and compositions for treatment of interferon-resistant tumors

Grant US-9439977-B2

United States of America

13 Sep 2016

Compositions and methods for therapeutic use

Grant US-8022044-B2

United States of America

20 Sep 2011

Methods and compositions for treatment of interferon-resistant tumors

Grant US-7691822-B2

United States of America

06 Apr 2010

Compositions and methods for therapeutic use

Grant US-7538093-B2

United States of America

26 May 2009

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity, including 4 additional patents.